Here is some other vaccine news of note for the week.
> With a grant of $11 million from the U.S. Department of Defense, investigators will test TapImmune’s breast cancer vaccine, TPIV110, in combination with Roche's Herceptin in a phase 2 study. Release
> The International AIDS Vaccine Initiative has started human testing of a novel HIV vaccine designed to initiate a key first step in the generation of broadly neutralizing antibodies. Release
> The University of Montana won a $10 million, five-year contract from the NIH to develop a new universal flu vaccine. Release
> Valneva nabbed FDA approval for an accelerated, seven-day dosing regimen for Japanese encephalitis vaccine Ixiaro. Release